Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Dec;19(3-4):151-67.
doi: 10.1023/b:mebr.0000043966.46964.e6.

Pathophysiology of stroke: lessons from animal models

Philipp Mergenthaler  1 , Ulrich Dirnagl, Andreas Meisel
Affiliations
Review

Pathophysiology of stroke: lessons from animal models

Philipp Mergenthaler et al. Metab Brain Dis. 2004 Dec.

Abstract

The current pathophysiological understanding of stroke is substantially based on experimental studies. Brain injury after cerebral ischemia develops from a complex signaling cascade that evolves in an at least partially unraveled spatiotemporal pattern. Early excitotoxicity can lead to fast necrotic cell death, which produces the core of the infarction. The ischemic penumbra that surrounds the infarct core suffers milder insults. In this area, both mild excitotoxic and inflammatory mechanisms lead to delayed cell death, which shows biochemical characteristics of apoptosis. While brain cells are challenged by these deleterious mechanisms, they activate innate protective programs of the brain, which can be studied by means of experimentally inducing ischemic tolerance (i.e., ischemic preconditioning). Importantly, cerebral ischemia not only affects the brain parenchyma, but also impacts extracranial systems. For example, stroke induces a dramatic immunosuppression via an overactivation of the sympathetic nervous system. As a result, severe bacterial infections such as pneumonia occur. Complex signaling cascades not only decide about cell survival, but also about the neurological deficit and the mortality after stroke. These mechanisms of damage and endogenous protection present distinct molecular targets that are the rational basis for the development of neuroprotective drugs.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Neuroreport. 1993 Jun;4(6):709-11 - PubMed
    1. Stroke. 1998 Dec;29(12):2455-60 - PubMed
    1. Stroke. 2002 Jul;33(7):1759-62 - PubMed
    1. Nat Med. 2001 Dec;7(12):1356-61 - PubMed
    1. Nature. 2003 Oct 30;425(6961):968-73 - PubMed

Publication types

LinkOut - more resources